In people with MS, changes in spinal fluid were linked to disability and brain scan findings.
Researchers measured 4,789 proteins in spinal fluid samples collected over time. Changes in 3,714 proteins were linked to health measures, including disability and brain scan findings. The patterns pointed to several processes, including nerve covering damage and loss of connections between nerve cells. Men showed more signs of tissue injury and increasing disability than women. Women showed more activity in processes that may help nerve tissue recover.
The study followed people with MS and people without MS. It looked at how spinal fluid changed over time in people with MS. This matters to researchers studying why MS may worsen. The differences between men and women may help explain why the disease takes different paths. The findings may also help guide future drug research.
The researchers studied 1,040 samples from 438 people with MS and people without MS. This study followed people over time; it did not test a treatment. The links between spinal fluid changes and disability do not show that those changes caused disability.
AI-generated summary — for informational purposes only, not medical advice
11/1/2026
Researchers compared blood from people with childhood-onset MS and healthy volunteers. They found DN
Read More11/1/2026
In 24 people with severe MS, stem cell treatment lowered signs of inflammation and nerve damage for
Read More11/1/2026
A review of 49 studies finds special brain scans can detect MS-related inflammation, but scan method
Read More10/9/2026
A mouse study suggests prepared red blood cells may calm MS-like immune attacks. Learn why liver cel
Read More10/7/2026
A 3D-printed immune implant eased advanced MS-like disease in mice without broadly weakening immunit
Read More10/6/2026
Researchers found immune cells that swap surface tags in MS. An MS treatment removed them in the stu
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Nature communications often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.